Otsuka Holdings Co., Ltd.
4578
Rank in Stocks
#578
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals,... Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Share Price
$78.91
Market Cap
$41.43B
Change (1 day)
-0.28%
Change (1 year)
45.76%
Country
JP
Trade Otsuka Holdings Co., Ltd. (4578)
Category
Healthcare
P/E ratio for Otsuka Holdings Co., Ltd. (4578)
P/E ratio as of October 2026 TTM: 16.13
According to Otsuka Holdings Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.13. At the end of 2024 the company had a P/E ratio of 13.57.
P/E ratio history for Otsuka Holdings Co., Ltd. from 2009 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 16.13 | 24.57% |
| 2025 | 12.95 | -4.55% |
| 2024 | 13.57 | -42.50% |
| 2023 | 23.60 | 35.30% |
| 2022 | 17.44 | -3.22% |
| 2021 | 18.02 | 11.43% |
| 2020 | 16.17 | -22.31% |
| 2019 | 20.82 | -29.46% |
| 2018 | 29.51 | 23.83% |
| 2017 | 23.83 | -20.06% |
| 2016 | 29.81 | 7.17% |
| 2015 | 27.82 | 114.73% |
| 2014 | 12.96 | -9.44% |
| 2013 | 14.31 | -3.53% |
| 2012 | 14.83 | 16.77% |
| 2011 | 12.70 | -14.81% |
| 2010 | 14.91 | -31.17% |
| 2009 | 21.66 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 43.73 | 171.07% |
US
|
|
| 39.77 | 146.52% |
US
|
|
| 80.21 | 397.23% |
US
|
|
| 121.17 | 651.09% |
US
|
|
| 25.53 | 58.24% |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.